![](../../files/images/goods/13311-84-7.png)
Flutamide
CAS No. 13311-84-7
Flutamide ( Niftolide; NSC 147834; NSC 251876; SCH 13521 )
Catalog No. M11320 CAS No. 13311-84-7
Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
Purity : >98%(HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
Size | Price / USD | Stock | Quantity |
200MG | 27 | In Stock |
![]() ![]() |
500MG | 41 | In Stock |
![]() ![]() |
1G | 43 | In Stock |
![]() ![]() |
Biological Information
-
Product NameFlutamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
-
DescriptionFlutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
-
SynonymsNiftolide; NSC 147834; NSC 251876; SCH 13521
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number13311-84-7
-
Formula Weight276.21
-
Molecular FormulaC11H11F3N2O3
-
Purity>98%(HPLC)
-
SolubilityEthanol: 55 mg/mL (199.12 mM); DMSO: 55 mg/mL (199.12 mM)
-
SMILESCC(C)C(NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1)=O
-
Chemical NameN-(4-nitro-3-(trifluoromethyl)phenyl)isobutyramide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chang HC, et al. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11173-7.
molnova catalog
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/ct2.png)
related products
-
ARD-2128
ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity.
-
Abbolactone
Spironolactone is a potent antagonist of the androgen receptor.
-
VPC-14228
VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.